Search Results

There are 4304 results for: content related to: CD133-Expressing Stem Cells Associated with Ovarian Metastases Establish an Endothelial Hierarchy and Contribute to Tumor Vasculature

  1. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges

    The Journal of Pathology

    Volume 229, Issue 3, February 2013, Pages: 355–378, Philipp Grosse-Gehling, Christine A Fargeas, Claudia Dittfeld, Yvette Garbe, Malcolm R Alison, Denis Corbeil and Leoni A Kunz-Schughart

    Version of Record online : 20 NOV 2012, DOI: 10.1002/path.4086

  2. You have full text access to this OnlineOpen article
    CD133 Is Essential for Glioblastoma Stem Cell Maintenance

    STEM CELLS

    Volume 31, Issue 5, May 2013, Pages: 857–869, Paola Brescia, Barbara Ortensi, Lorenzo Fornasari, Daniel Levi, Giovanni Broggi and Giuliana Pelicci

    Version of Record online : 24 APR 2013, DOI: 10.1002/stem.1317

  3. You have free access to this content
    Characterization of Renal Progenitors Committed Toward Tubular Lineage and Their Regenerative Potential in Renal Tubular Injury

    STEM CELLS

    Volume 30, Issue 8, August 2012, Pages: 1714–1725, Maria Lucia Angelotti, Elisa Ronconi, Lara Ballerini, Anna Peired, Benedetta Mazzinghi, Costanza Sagrinati, Eliana Parente, Mauro Gacci, Marco Carini, Mario Rotondi, Agnes B. Fogo, Elena Lazzeri, Laura Lasagni and Paola Romagnani

    Version of Record online : 24 JUL 2012, DOI: 10.1002/stem.1130

  4. You have full text access to this Open Access content
    CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation

    Cancer Science

    Volume 102, Issue 7, July 2011, Pages: 1313–1321, Hiroshi Fukamachi, Shu Shimada, Kosei Ito, Yoshiaki Ito and Yasuhito Yuasa

    Version of Record online : 9 MAY 2011, DOI: 10.1111/j.1349-7006.2011.01947.x

  5. You have full text access to this OnlineOpen article
    Combined Characterization of microRNA and mRNA Profiles Delineates Early Differentiation Pathways of CD133+ and CD34+ Hematopoietic Stem and Progenitor Cells

    STEM CELLS

    Volume 29, Issue 5, May 2011, Pages: 847–857, Ute Bissels, Stefan Wild, Stefan Tomiuk, Markus Hafner, Hartmut Scheel, Aleksandra Mihailovic, Yeong-Hoon Choi, Thomas Tuschl and Andreas Bosio

    Version of Record online : 19 APR 2011, DOI: 10.1002/stem.627

  6. You have full text access to this Open Access content
    Both CD133+ and CD133 subpopulations of A549 and H446 cells contain cancer-initiating cells

    Cancer Science

    Volume 100, Issue 6, June 2009, Pages: 1040–1046, Xiangjiao Meng, Ming Li, Xiuwen Wang, Yawei Wang and Daoxin Ma

    Version of Record online : 20 FEB 2009, DOI: 10.1111/j.1349-7006.2009.01144.x

  7. CD133 and CD133-regulated nucleophosmin linked to 5-fluorouracil susceptibility in human colon cancer cell line SW620

    ELECTROPHORESIS

    Volume 35, Issue 4, February 2014, Pages: 522–532, Kyung-Hee Kim, Byong Chul Yoo, Won Ki Kim, Jun Pyu Hong, Kun Kim, Eun Young Song, Jae Yong Lee, Jae Youl Cho and Ja-Lok Ku

    Version of Record online : 16 DEC 2013, DOI: 10.1002/elps.201300364

  8. You have free access to this content
    Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition

    STEM CELLS

    Volume 26, Issue 12, December 2008, Pages: 3027–3036, Christine E. Eyler, Wen-Chi Foo, Katherine M. LaFiura, Roger E. McLendon, Anita B. Hjelmeland and Jeremy N. Rich

    Version of Record online : 18 SEP 2008, DOI: 10.1634/stemcells.2007-1073

  9. You have free access to this content
    CD133+ liver cancer stem cells from methionine adenosyl transferase 1A–deficient mice demonstrate resistance to transforming growth factor (TGF)-β–induced apoptosis

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1277–1286, Wei Ding, Marialena Mouzaki, Hanning You, Joshua C. Laird, Jose Mato, Shelly C. Lu and C. Bart Rountree

    Version of Record online : 19 NOV 2008, DOI: 10.1002/hep.22743

  10. You have free access to this content
    CD133+ Cancer Stem Cell–like Cells Derived from Uterine Carcinosarcoma (Malignant Mixed Müllerian Tumor)

    STEM CELLS

    Volume 29, Issue 10, October 2011, Pages: 1485–1495, Batsuren Choijamts, Shiro Jimi, Toru Kondo, Yasuko Naganuma, Taichi Matsumoto, Masahide Kuroki, Hiroshi Iwasaki and Makoto Emoto

    Version of Record online : 27 SEP 2011, DOI: 10.1002/stem.711

  11. You have full text access to this Open Access content
    Identification and characterization of cancer stem cells in ovarian yolk sac tumors

    Cancer Science

    Volume 101, Issue 10, October 2010, Pages: 2179–2185, Shiro Suzuki, Mikio Terauchi, Tomokazu Umezu, Hiroaki Kajiyama, Kiyosumi Shibata, Akihiro Nawa and Fumitaka Kikkawa

    Version of Record online : 7 JUL 2010, DOI: 10.1111/j.1349-7006.2010.01672.x

  12. CD133+CD44+ Cells Mediate in the Lung Metastasis of Osteosarcoma

    Journal of Cellular Biochemistry

    Volume 116, Issue 8, August 2015, Pages: 1719–1729, Aina He, Xiaojing Yang, Yujing Huang, Tao Feng, Yonggang Wang, Yuanjue Sun, Zan Shen and Yang Yao

    Version of Record online : 10 JUN 2015, DOI: 10.1002/jcb.25131

  13. You have free access to this content
    Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-β

    Hepatology

    Volume 51, Issue 5, May 2010, Pages: 1635–1644, Hanning You, Wei Ding and C. Bart Rountree

    Version of Record online : 28 JAN 2010, DOI: 10.1002/hep.23544

  14. CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway

    Histopathology

    Volume 60, Issue 7, June 2012, Pages: 1144–1155, Hervé Sartelet, Tina Imbriglio, Carine Nyalendo, Elie Haddad, Borhane Annabi, Michel Duval, Raouf Fetni, Kokta Victor, Lubo Alexendrov, Daniel Sinnett, Monique Fabre and Gilles Vassal

    Version of Record online : 6 MAR 2012, DOI: 10.1111/j.1365-2559.2012.04191.x

  15. Cystogenic potential of CD133+ progenitor cells of human polycystic kidneys

    The Journal of Pathology

    Volume 225, Issue 1, September 2011, Pages: 129–141, Raquel Carvalhosa, Ilaria Deambrosis, Paola Carrera, Chiara Pasquino, Francesca Rigo, Maurizio Ferrari, Fedele Lasaponara, Andrea Ranghino, Luigi Biancone, Giuseppe Segoloni, Benedetta Bussolati and Giovanni Camussi

    Version of Record online : 27 JUN 2011, DOI: 10.1002/path.2920

  16. CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV

    Pediatric Blood & Cancer

    Volume 60, Issue 1, January 2013, Pages: 45–52, Joseph G. Pressey, Marilyn C. Haas, Christine S. Pressey, Virginia M. Kelly, Jacqueline N. Parker, G. Yancey Gillespie and Gregory K. Friedman

    Version of Record online : 9 MAR 2012, DOI: 10.1002/pbc.24117

  17. Oct-4A isoform is expressed in human cord blood-derived CD133 stem cells and differentiated progeny

    Cell Proliferation

    Volume 42, Issue 3, June 2009, Pages: 265–275, M.  Howe, J.  Zhao, Y. Bodenburg, C. P.  McGuckin, N.  Forraz, R. G.  Tilton, R. J.  Urban and L.  Denner

    Version of Record online : 25 MAR 2009, DOI: 10.1111/j.1365-2184.2009.00593.x

  18. Expression of CD133-1 and CD133-2 in ovarian cancer

    International Journal of Gynecological Cancer

    Volume 18, Issue 3, May/June 2008, Pages: 506–514, G. FERRANDINA, G. BONANNO, L. PIERELLI, A. PERILLO, A. PROCOLI, A. MARIOTTI, M. CORALLO, E. MARTINELLI, S. RUTELLA, A. PAGLIA, G. ZANNONI, S. MANCUSO and G. SCAMBIA

    Version of Record online : 14 SEP 2007, DOI: 10.1111/j.1525-1438.2007.01056.x

  19. You have free access to this content
    Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver

    Hepatology

    Volume 48, Issue 6, December 2008, Pages: 1964–1978, Atsushi Suzuki, Sayaka Sekiya, Makiko Onishi, Naoko Oshima, Hiroshi Kiyonari, Hiromitsu Nakauchi and Hideki Taniguchi

    Version of Record online : 3 OCT 2008, DOI: 10.1002/hep.22558

  20. You have free access to this content
    Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival

    Cancer

    Volume 119, Issue 1, 1 January 2013, Pages: 26–35, Thilo Sprenger, Lena-Christin Conradi, Tim Beissbarth, Heiko Ermert, Kia Homayounfar, Peter Middel, Josef Rüschoff, Hendrik A. Wolff, Philipp Schüler, B. Michael Ghadimi, Claus Rödel, Heinz Becker, Franz Rödel and Torsten Liersch

    Version of Record online : 26 JUN 2012, DOI: 10.1002/cncr.27703